Wu Xiaoxia,Liu Wenyue,Sun Xue,et al.Risk factors and prognosis of recurrent cholangitis after Kasai in biliary atresia patients[J].Journal of Clinical Pediatric Surgery,2023,22(03):244-248.[doi:10.3760/cma.j.cn101785-202212005-008]
胆道闭锁患儿Kasai手术后频发胆管炎的危险因素及预后分析
- Title:
- Risk factors and prognosis of recurrent cholangitis after Kasai in biliary atresia patients
- Keywords:
- Biliary Atresia; Cholangitis; Prognosis; Root Cause Analysis
- 摘要:
- 目的 探讨胆道闭锁(biliary atresia,BA)患儿Kasai手术后频发胆管炎的危险因素及预后。方法 回顾性分析山西省儿童医院2018年1月至2021年9月因BA行Kasai手术后合并胆管炎患儿的临床资料和随访资料,根据患儿6个月内胆管炎发作次数是否≥3次分为频发胆管炎组和偶发胆管炎组,比较两组性别分布、术前身体质量指数(body mass index,BMI)、术前巨细胞病毒(cytomegalovirus,CMV)感染、行Kasai手术年龄、肝纤维化分级、术前及术后2周肝功能指标和早期胆管炎发生情况,采用Cox回归分析筛选频发胆管炎的危险因素,并比较两组患儿术后黄疸清除(jaundice clearance,JC)率及自体肝生存率。结果 本研究共纳入60例因BA行Kasai手术后发生胆管炎患儿,其中频发胆管炎组20例,偶发胆管炎组40例,两组患儿性别、术前BMI指数、术前CMV感染、Kasai手术年龄和肝纤维化分级比较差异均无统计学意义(P＞0.05)。频发胆管炎组术前总胆汁酸水平显著低于偶发胆管炎组(Z=-2.070,P＜0.05)。两组患儿术前丙氨酸转氨酶(alanine transaminase,ALT)[(169.47±93.53)比(173.96±96.25) U/L]、天冬氨酸转氨酶(aspartate trans-aminase,AST)[242.50(169.68,296.13)比244.50(148.50,297.00) U/L]、γ-谷氨酰转肽酶(gamma-glutamyl transferase,GGT)[572.00(310.75,895.75)比388.00(245.50,695.25) U/L]、总胆红素(total bilirubin,TBIL)[(219.61±73.08)比(207.38±58.63)μmol/L]、直接胆红素(direct bilirubin,DBIL)[122.70(104.50,163.25)比116.70(81.42,158.35)μmol/L]和白蛋白(albumin,Alb)[(36.27±2.91)比(37.88±4.90) g/L]水平差异无统计学意义(P＞0.05)。两组患儿术后2周ALT[(211.23±144.87)比(229.87±104.76) U/L]、AST[162.50(108.17,225.75)比196.50(160.75,235.43) U/L]、GGT[(742.85±438.09)比(584.05±385.31) U/L]、TBIL[136.20(86.05,190.23)比145.50(95.73,213.90)μmol/L]、DBIL[79.85(60.88,122.83)比90.00(61.30,129.30)μmol/L]和Alb[(37.92±5.55)比(39.22±4.55) g/L]水平差异无统计学意义(P＞0.05)。频发胆管炎组早期胆管炎发生率显著高于偶发胆管炎组,差异有统计学意义(χ2=9.909,P＜0.05)。Cox回归分析结果显示,早期胆管炎是BA患儿Kasai手术后频发胆管炎的危险因素(HR=4.947,95%CI:1.754~13.948,P＜0.05)。频发胆管炎组术后3个月、6个月JC率低于偶发胆管炎组,但差异无统计学意义(P＞0.05),频发胆管炎组术后12个月JC率显著低于偶发胆管炎组,差异有统计学意义(χ2=5.179,P＜0.05)。两组术后1年自肝生存率差异无统计学意义(P＞0.05)。结论 早期胆管炎是BA Kasai手术后频发胆管炎的独立危险因素,频发胆管炎会影响手术后黄疸清除。
- Abstract:
- Objective To explore the risk factors and outcomes of recurrent cholangitis after Kasai in biliary atresia (BA) patients.Methods Retrospective review was conducted for clinical and follow-up data of 60 BA children with cholangitis after Kasai procedure from January 2018 to September 2021.According to whether the frequency of cholangitis episodes was more than or equal to 3 times in half a year,they were divided into two groups of recurrent cholangitis (n=20) and occasional cholangitis (n=40).Gender,preoperative body mass index (BMI),cytomegalovirus (CMV) infection,age at Kasai surgery,liver fibrosis grade,serum levels of liver function parameters at preoperation and Day 14 postoperation and the occurrence of early cholangitis were compared between two groups.Cox regression analysis was performed for estimating the risk factors of recurrent cholangitis.Postoperative jaundice clearance (JC) rate and postoperative native liver survival rate were also compared between two groups.Results No significant differences existed in gender,preoperative BMI,CMV infection,age at Kasai or liver fibrosis grade (P>0.05).Serum total bile acid level at preoperation was significantly lower in recurrent cholangitis group than that in occasional cholangitis group (Z=-2.070,P<0.05).Alanine transaminase(ALT)[(169.47±93.53)U/L],Aspartate trans aminase(AST)[(173.96±96.25)U/L],[242.50(169.68,296.13)ratio 244.50(148.50,297.00)U/L],gamma-glutamyl transferase(GGT)[572.00(310.75,895.75)than 388.00(245.50,695.25)U/L],total bilirubin,(219.61±73.08)ratio(207.38±58.63)μmol/L),direct bilirubin(DBIL)ratio(122.70(104.50,163.25)ratio 116.70(81.42,158.35)μmol/L］and albumin,Alb[(36.27±2.91)vs.(37.88±4.90)g/L]at preoperation between 2 groups had no significant difference(P>0.05).ALT[(211.23±144.87)to(229.87±104.76)U/L]and AST[162.50(108.17,225.75)to 196.50(160.75,235.43)U/L],GGT[(742.85±438.09)vs.(584.05±385.31)U/L],TBIL[136.20(86.05,190.23)vs.145.50(95.73,213.90)μmol/L],DBIL[79.85(60.88,122.83)vs.90.00(61.30,129.30)μmol/L]and Alb[(37.92±5.55)vs.(39.22±4.55)g/L]at day 14 postoperation between 2 groups were not significantly different(P>0.05).The incidence of early cholangitis was significantly higher in recurrent cholangitis group than that in occasional cholangitis group (χ2=9.909,P<0.05).Cox regression analysis revealed that early cholangitis was risk factor for recurrent cholangitis; JC rate of recurrent cholangitis group was lower than that of occasional cholangitis group at Month 3/6 postoperation.However,the difference was not statistically significant (P>0.05).JC rate at Month 12 postoperation was significantly lower in recurrent cholangitis group than that in occasional cholangitis group (χ2=5.179,P<0.05).No significant inter-group difference existed in native liver survival rate at 1 year postoperation (P>0.05).Conclusion Early cholangitis is an independent risk factor for recurrent cholangitis after Kasai in BA children.And recurrent cholangitis affects the postoperative jaundice clearance.
参考文献/References:
[1] Kasahara M,Umeshita K,Sakamoto S,et al.Liver transplantation for biliary atresia:a systematic review[J].Pediatr Surg Int,2017,33(12):1289-1295.DOI:10.1007/s00383-017-4173-5.
[2] Ramos-Gonzalez G,Elisofon S,Dee EC,et al.Predictors of need for liver transplantation in children undergoing hepatoportoenterostomy for biliary atresia[J].J Pediatr Surg,2019,54(6):1127-1131.DOI:10.1016/j.jpedsurg.2019.02.051.
[3] de Ville de Goyet J,Illhardt T,Chardot C,et al.Variability of care and access to transplantation for children with biliary atresia who need a liver replacement[J].J Clin Med,2022,11(8):2142.DOI:10.3390/jcm11082142.
[4] Chen SY,Lin CC,Tsan YT,et al.Number of cholangitis episodes as a prognostic marker to predict timing of liver transplantation in biliary atresia patients after Kasai portoenterostomy[J].BMC Pediatr,2018,18(1):119.DOI:10.1186/s12887-018-1074-2.
[5] Lee JY,Lim LTK,Quak SH,et al.Cholangitis in children with biliary atresia:health-care resource utilisation[J].J Paediatr Child Health,2014,50(3):196-201.DOI:10.1111/jpc.12463.
[6] Liu J,Dong R,Chen G,et al.Risk factors and prognostic effects of cholangitis after Kasai procedure in biliary atresia patients:a retrospective clinical study[J].J Pediatr Surg,2019,54(12):2559-2564.DOI:10.1016/j.jpedsurg.2019.08.026.
[7] 葛亮,詹江华,高伟,等.胆道闭锁Kasai术后早期行肝移植手术的危险因素分析[J].天津医药,2019,47(4):351-355.DOI:10.11958/20190343. Ge L,Zhan JH,Gao W,et al.Risk factors of early liver transplantation after Kasai procedure for biliary atresia[J].Tianjin Med J,2019,47(4):351-355.DOI:10.11958/20190343.
[8] Chung PHY,Wong KKY,Tam PKH.Predictors for failure after Kasai operation[J].J Pediatr Surg,2015,50(2):293-296.DOI:10.1016/j.jpedsurg.2014.11.015.
[9] 郭鑫,孙雪,任红霞.102例胆道闭锁Kasai术后胆管炎分析[J].临床小儿外科杂志,2017,16(2):146-150.DOI:10.3969/j.issn.1671-6353.2017.02.010. Guo X,Sun X,Ren HX.Analysis of cholangitis in patients with biliary atresia after Kasai operation[J].J Clin Ped Sur,2017,16(2):146-150.DOI:10.3969/j.issn.1671-6353.2017.02.010.
[10] 中华医学会小儿外科学分会肝胆外科学组.胆道闭锁Kasai术后胆管炎诊疗专家共识(2022版)[J].中华小儿外科杂志,2022,43(9):769-774.DOI:10.3760/cma.j.cn421158-20220427-00308. Group of Pediatric Hepatobiliary Surgery,Society of Pediatric Surgery,Chinese Medical Association:Expert Consensus on Diagnosing&Treating Cholangitis after Kasai Operation for Biliary Atresia (2022 Edition)[J].Chin J Pediatr Surg,2022,43(9):769-774.DOI:10.3760/cma.j.cn421158-20220427-00308.
[11] Chen G,Liu J,Huang YL,et al.Preventive effect of prophylactic intravenous antibiotics against cholangitis in biliary atresia:a randomized controlled trial[J].Pediatr Surg Int,2021,37(8):1089-1097.DOI:10.1007/s00383-021-04916-z.
[12] Jiang H,Gao PF,Chen HD,et al.The prognostic value of CD8+and CD45RO+T cells infiltration and beclin1 expression levels for early postoperative cholangitis of biliary atresia patients after Kasai operation[J].J Korean Med Sci,2018,33(30):e198.DOI:10.3346/jkms.2018.33.e198.
[13] 葛亮,苟庆云,赵金凤,等.肝脏CD4、CD8及CD68表达与Kasai术后胆管炎的关系研究[J].天津医药,2020,48(8):720-725.DOI 10.11958/20192986. Ge L,Gou QY,Zhao JF,et al.Relationship between expressions of CD4,CD8 and CD68 in liver and cholangitis after Kasai operation[J].Tianjin Med J,2020,48(8):720-725.DOI:10.11958/20192986.
[14] Harpavat S,Hawthorne K,Setchell KDR,et al.Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy[J/OL].Hepatology,2022.DOI:10.1002/hep.32800.
[15] Karpen SJ,Kelly D,Mack C,et al.Ileal bile acid transporter inhibition as an anticholestatic therapeutic target in biliary atresia and other cholestatic disorders[J].Hepatol Int,2020,14(5):677-689.DOI:10.1007/s12072-020-10070-w.
[16] Chusilp S,Sookpotarom P,Tepmalai K,et al.Prognostic values of serum bilirubin at 7th day post-Kasai for survival with native livers in patients with biliary atresia[J].Pediatr Surg Int,2016,32(10):927-931.DOI:10.1007/s00383-016-3951-9.
[17] Wang ZM,Chen YJ,Peng CH,et al.Five-year native liver survival analysis in biliary atresia from a single large Chinese center:the death/liver transplantation hazard change and the importance of rapid early clearance of jaundice[J].J Pediatr Surg,2019,54(8):1680-1685.DOI:10.1016/j.jpedsurg.2018.09.025.
[18] Nightingale S,Stormon MO,O’Loughlin EV,et al.Early posthepatoportoenterostomy predictors of native liver survival in biliary atresia[J].J Pediatr Gastroenterol Nutr,2017,64(2):203-209.DOI:10.1097/MPG.0000000000001289.
相似文献/References:
[1]毛永忠,汤绍涛,阮庆兰,等.胆道闭锁肝组织MMP-1、MMP-2、TIMP-1的表达与预后研究[J].临床小儿外科杂志,2007,6(01):5.
[2]毛永忠,汤绍涛,阮庆兰,等.胆道闭锁肝脏组织MMP-2、TGF-β_1的表达及意义[J].临床小儿外科杂志,2007,6(03):5.
[3]董淳强 杨体泉 董昆. 胆道闭锁术后早期胆管炎风险因素分析[J].临床小儿外科杂志,2013,12(05):348.
[4]陈功 郑珊 孙松. 不同年龄胆道闭锁患儿手术效果分析[J].临床小儿外科杂志,2014,13(01):22.
[5]谭梅军 陶强 黄金狮. IL-17在胆道闭锁患儿肝组织中的表达及意义[J].临床小儿外科杂志,2014,13(04):302.
[6]杨文萍 吴艳 张守华. 胆道闭锁患者肝脏组织病理改变的综合评价[J].临床小儿外科杂志,2015,14(01):10.
[7]李康 阳历 汤绍涛. 胆道闭锁患者肝内胆管γδT 细胞和调节性T细胞浸润及意义[J].临床小儿外科杂志,2015,14(01):16.
[8]刘丹丹 詹江华 高伟. 胆道闭锁患者肝门的病理解剖学研究[J].临床小儿外科杂志,2015,14(01):20.
[9]张震 李龙 乔国梁. 胆道闭锁Kasai术后生存率及条件生存率分析[J].临床小儿外科杂志,2015,14(01):25.
[10]庞文博 张廷冲 彭春辉. 强力抗感染和免疫调节预防Kasai术后近期胆管炎[J].临床小儿外科杂志,2015,14(01):29.
[11]余梦楠 刘钢 黄柳明 王伟. 胆道闭锁术后反复发作性胆管炎的细菌谱分析及抗生素选择[J].临床小儿外科杂志,2012,11(03):187.
[J].Journal of Clinical Pediatric Surgery,2012,11(03):187.
[12]王培,冯杰雄.胆道闭锁术后胆管炎抗生素分级治疗的多中心研究方案[J].临床小儿外科杂志,2019,18(11):922.[doi:10.3969/j.issn.1671—6353.2019.11.006]
Wang Pei,Feng Jiexiong.The antibiotics treatment of cholangitis Post-Kasai Portoenterostomy: A multi-center study protocol[J].Journal of Clinical Pediatric Surgery,2019,18(03):922.[doi:10.3969/j.issn.1671—6353.2019.11.006]
[13]詹江华,王智茹.聚焦胆道闭锁诊疗相关热点问题[J].临床小儿外科杂志,2023,22(03):201.[doi:10.3760/cma.j.cn101785-202212026-001]
Zhan Jianghua,Wang Zhiru.Focusing upon hot issues of diagnosing and treating biliary atresia[J].Journal of Clinical Pediatric Surgery,2023,22(03):201.[doi:10.3760/cma.j.cn101785-202212026-001]
[14]詹江华,孙溶涓,王智茹,等.日本《胆道闭锁临床实践指南》解读[J].临床小儿外科杂志,2023,22(03):205.[doi:10.3760/cma.j.cn101785-202212025-002]
Zhan Jianghua,Sun Rongjuan,Wang Zhiru,et al.Interpretations of Clinical Practice Guidelines for Biliary Atresia in Japan[J].Journal of Clinical Pediatric Surgery,2023,22(03):205.[doi:10.3760/cma.j.cn101785-202212025-002]
[15]赵一霖,吴晓霞,徐晓丹,等.巨细胞病毒感染对胆道闭锁Kasai手术预后影响的研究[J].临床小儿外科杂志,2023,22(03):232.[doi:10.3760/cma.j.cn101785-202212017-006]
Zhao Yilin,Wu Xiaoxia,Xu Xiaodan,et al.Prognosis of biliary atresia associated with cytomegalovirus[J].Journal of Clinical Pediatric Surgery,2023,22(03):232.[doi:10.3760/cma.j.cn101785-202212017-006]
[16]王磊,兰照平,高琪,等.胆道闭锁患儿Kasai手术后胆管炎的危险因素分析[J].临床小儿外科杂志,2023,22(11):1039.[doi:10.3760/cma.j.cn101785-202211061-007]
Wang Lei,Lan Zhaoping,Gao Qi,et al.Analysis of risk factors for cholangitis after Kasai procedure in biliary atresia children[J].Journal of Clinical Pediatric Surgery,2023,22(03):1039.[doi:10.3760/cma.j.cn101785-202211061-007]
备注/Memo
收稿日期:2022-12-3。
基金项目:山西省卫生健康委课题(2022074),山西省儿童医院院内课题(2021027)
通讯作者:任红霞,Email:renhongxia100@sina.com